Adverse event during Covaxin trials: Bharat Biotech confirms.
Adverse event during Covaxin trials: Bharat Biotech confirms.
Bharat Biotech confirms that there was a adverse event during coronavirus vaccine trials in August 2020. According to Bharat Biotech-
They have reported to ADSCO-DCGI, within 24 hours of occurrence of the event.
They have rejected the report that it did not report an adverse event during trial in August.
Bharat Biotech and ICMR jointly working on indigenous coronavirus vaccine candidate.
CDSCO has also given its approval to Bharat Biotech to launch the phase III trials of COVID-19 vaccine candidate.
